Morgan Stanley upgraded Lemonade (LMND) to Equal Weight from Underweight with a price target of $42, up from $23, following the investor day. Lemonade “charted an ambitious goal” of growing its business from $1B in premiums to $10B over the next few years, the analyst tells investors in a research note. The firm adds the company charting a path to net profit positive exiting 2027, which is significantly more optimistic than consensus estimates. It believes the next phase of Lemonade’s growth will be driven by its “differentiated” technology.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.